A newer type of diabetes, pancreatogenic diabetes or type 3c diabetes (T3cD) being misdiagnosed as type 2 diabetes (T2D)
Researchers have identified new type 3c diabetes (also known as pancreatogenic diabetes. T3cD). Damage to the pancreas due to tumors, inflammation or surgery causes the development of type 3c diabetes. Type 3c diabetes reduces insulin secretion from beta cells (required to control blood glucose levels. Glycemic control) and also reduces the secretion of digestive enzymes (proteins) and other hormones (for the digestion of the food). Diabetes may not be developed in all people with pancreas diseases, damage or injury. Diabetes development may take more than ten years in most of the people with pancreatic diseases, damage or injury.
Type 3c diabetes is being misdiagnosed as type 2 diabetes by the medical professionals, due to the delay in the development of type 3c diabetes. Medical professionals failed to find an association between the pancreas diseases (damage or injury) and pancreatogenic diabetes (or the development of type 3c diabetes. T3cD).
A large-scale study was conducted among two million patients, all age groups, in England. Researchers used the Royal College of General Practitioners Research and Surveillance Database (RCGP RSC) to find out the prevalence of type 3c diabetes. The study also focused on finding how patients with type 3c diabetes are controlling their blood sugar levels.
Researchers looked into those patients who were diagnosed with diabetes after the damage to pancreas due to events such as hemochromatosis, cystic fibrosis, pancreatic cancer and tumors, pancreatitis and pancreatic surgery, which may increase the risk of the development of type 3c diabetes or pancreatogenic diabetes (T3cD). In newly diagnosed adult patients.
These results increase concerns that the type 3c diabetes is more common and this type of diabetes is not being diagnosed properly. Misdiagnosis of type 3c diabetes is a waste of time, money and a risk of high blood sugar or glucose levels. Drugs such as gliclazide and type 2 diabetes (T2D) treatment are not effective in the treatment of type 3c diabetes. This small study shows benefits for patients with type 3c diabetes with an insulin injection and digestive enzymes (in a tablet, liquid or pill form) along with the food. Some tips to prevent the development of type 3c diabetes or pancreatogenic diabetes (T3cD) are
10. Benefits With Closed-Loop Artificial Pancreas
11. Study Of Artificial Pancreas
12. New Approach To Stimulate Beta Cells
13. New Blood Glycated Protein CD59 Or GCD59 Test To Diagnose Gestational Diabetes Early
14. Kidney failure, amputations, blindness, heart attack and stroke complications by delaying insulin therapy among patients with type 2 diabetes
15. Raspberries could lower inflammation, high blood sugar or glucose levels and improves insulin sensitivity
16. Urocortin 2 (Ucn2) gene transfer therapy improves insulin sensitivity and reduces blood sugar or glucose (HbA1c) levels
17. A single dose of glucagon receptor antibody found to be as effective in reducing the insulin need
18. Prevention of heart diseases with an extra injection of insulin after meals in patients with type 1 diabetes
Pancreatitis : Pancreas release glucagon and insulin hormone and releases them into the bloodstream to control blood sugar levels. The pancreas also produces digestive enzymes and releases them into the small intestine for the digestion of the food. Sometimes, these digestive enzymes were activated before being released into the small intestine. These enzymes attack the pancreas causing inflammation to the pancreas. This inflammation leads to pancreatitis. Symptoms of pancreatitis are.
The Diabetes News Chronicle does not provide medical advice, diagnosis or treatment. Information in Diabetes News Chronicle is to support and not to replace medical advice given by the surgeon or physician or doctor. Published article is not a medical advice by the OWNER of the "Diabetes News Chronicle" website or by the AUTHOR of the article.
Published by Jammi Vasista, Chennai, India.